Oriola issues a new outlook for 2022 after finalizing the combining of Kronans Apotek and Apoteksgruppen into a new company
Oriola Corporation Insider information 3 October 2022 at 12.20 p.m.
Oriola issues a new outlook for 2022 after finalizing the combining of Kronans Apotek and Apoteksgruppen into a new company
Oriola Corporation issues a new outlook for 2022 after finalizing the combining of Oriola’s Kronans Apotek and Euroapotheca’s Apoteksgruppen into a new jointly owned company.
The new outlook for 2022
The adjusted EBIT for the continuing operations is estimated to increase from the 2021 level. The new outlook is based on Oriola’s continuing operations.
The COVID-19 pandemic continues and severity as well as duration of the pandemic remain unclear in Oriola’s operating environment. Furthermore, the recent overall inflationary increases and related cost pressures may have a significant impact on Oriola’s profitability.
The comparable adjusted EBIT in 2021 was EUR 14.9 million for the continuing operations.
The previous outlook for 2022 (published on 18 February 2022)
The comparable adjusted EBIT is estimated to increase from the 2021 level.
The COVID-19 pandemic continues and severity as well as duration of the pandemic remain unclear in Oriola’s operating environment. Furthermore, the recent overall inflationary increases and related cost pressures may have a significant impact on Oriola’s profitability.
The outlook remains based on current group structure, including both continuing operations and discontinued operations. The comparable adjusted EBIT in 2021 was EUR 26.3 million.
Oriola Corporation
Mikael Wegmüller
VP, Communications and Sustainability
Tel. +358 40 776 2314
email: mikael.wegmuller@oriola.com
Distribution
Nasdaq Helsinki
Key media
Released by:
Oriola Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola.com